Antoni Aguilar-Mogas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Antoni Aguilar-Mogas has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Marta Sales-Pardo
Universitat Rovira i Virgili
5 shared publications - Roger Guimerà
Department of Chemical Engineering, Universitat Rovira i Virgili, Tarragona, Catalonia
5 shared publications - Josep Maria Bofill
Universitat de Barcelona
4 shared publications Xavier Giménez
Departament de Química Física, Universitat de Barcelona, Barcelona, Spain
4 shared publicationsJosep Maria Bofill
Departament de Química Orgànica, Universitat de Barcelona, Barcelona, Spain
3 shared publications- Oscar Yanes
Universitat Rovira i Virgili
3 shared publications
Latest Publications
- Open Access
Challenges and Health Disparities in Prostate Cancer: Healthcare Access as a Driver of Inequities in a Rural Hospital Network
Background: Prostate cancer is the most common male cancer, and second most common cause of cancer mortality in the US. Disparities abound in this disease for reasons that need further study, including social and ethnic barriers, geographic barriers, and biological differences. North Carolina is the second largest state by rural population measures (3.5 million), which provides ample geography to study these disparities. Materials and Methods: A dataset containing all patients with a medical record documenting a diagnosis of and/or treatment for de novo prostate cancer within the mostly rural ECU Health 9-hospital system was characterized over a 20-year period for structural inequities, access barriers, and biological differences. Results: Stages and outcomes of prostate cancer changed temporally, reflecting changes in screening, treatment, and inclusion of prognostic factors such as prostate-specific antigen, Gleason score, and other factors. Late stage (4) prostate cancer disproportionately affected our system as a whole and smaller community hospitals, with higher death rates seen in community, mostly rural programs that lack access to all required components of care. Conclusion: Stages of prostate cancer changed considerably over the study period, reflecting changes in screening recommendations, and staging criteria. Late stage (4) disease increased over the analytic period, was higher than NCDB references by period, and disproportionately affected community programs where resources were sparse, correlating with worse outcomes.
Open AccessChallenges and Health Disparities in Prostate Cancer: Healthcare Access as a Driver of Inequities in a Rural Hospital Network
Background: Prostate cancer is the most common male cancer, and second most common cause of cancer mortality in the US. Disparities abound in this disease for reasons that need further study, including social and ethnic barriers, geographic barriers, and biological differences. North Carolina is the second largest state by rural population measures (3.5 million), which provides ample geography to study these disparities. Materials and Methods: A dataset containing all patients with a medical record documenting a diagnosis of and/or treatment for de novo prostate cancer within the mostly rural ECU Health 9-hospital system was characterized over a 20-year period for structural inequities, access barriers, and biological differences. Results: Stages and outcomes of prostate cancer changed temporally, reflecting changes in screening, treatment, and inclusion of prognostic factors such as prostate-specific antigen, Gleason score, and other factors. Late stage (4) prostate cancer disproportionately affected our system as a whole and smaller community hospitals, with higher death rates seen in community, mostly rural programs that lack access to all required components of care. Conclusion: Stages of prostate cancer changed considerably over the study period, reflecting changes in screening recommendations, and staging criteria. Late stage (4) disease increased over the analytic period, was higher than NCDB references by period, and disproportionately affected community programs where resources were sparse, correlating with worse outcomes.
- Open Access
- 21 July 2025
- Published by Taylor & Francis in Journal of Health Equity
- Vol. 2 (1)
The impact of social drivers of health on the experience of the caring process: how the perceived quality of care can help identify health inequities
- 21 July 2025
- Published by Taylor & Francis in Journal of Health Equity
- Vol. 2 (1)
Open AccessThe impact of social drivers of health on the experience of the caring process: how the perceived quality of care can help identify health inequities
- Open Access
Obesity causes irreversible mitochondria failure in visceral adipose tissue despite successful anti-obesogenic lifestyle-based interventions
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most pathological features were successfully reverted, we observed a high degree of metabolic dysfunction irreversibility in visceral white adipose tissue, characterised by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and apparent global phenotypic recovery, obesity specifically triggered in visceral adipose a cascade of events progressing from mitochondrial metabolic and proteostatic defects to widespread cellular stress, which compromises its biosynthetic and recycling capacity. Our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in white adipose tissue, becoming a significant milestone in disease progression.
Open AccessObesity causes irreversible mitochondria failure in visceral adipose tissue despite successful anti-obesogenic lifestyle-based interventions
Metabolic plasticity is the ability of a biological system to adapt its metabolic phenotype to different environmental stressors. We used a whole-body and tissue-specific phenotypic, functional, metabolomic and transcriptomic approach to systematically assess metabolic plasticity in diet-induced obese mice after a combined nutritional and exercise intervention. Although most pathological features were successfully reverted, we observed a high degree of metabolic dysfunction irreversibility in visceral white adipose tissue, characterised by abnormal mitochondrial morphology and functionality. Despite two sequential therapeutic interventions and apparent global phenotypic recovery, obesity specifically triggered in visceral adipose a cascade of events progressing from mitochondrial metabolic and proteostatic defects to widespread cellular stress, which compromises its biosynthetic and recycling capacity. Our data indicate that obesity prompts a lasting metabolic fingerprint that leads to a progressive breakdown of metabolic plasticity in white adipose tissue, becoming a significant milestone in disease progression.
- Top Cited PapersOpen Access
- 31 January 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (5) , eaav6971
A Bayesian machine scientist to aid in the solution of challenging scientific problems
A Bayesian machine scientist uncovers closed-form mathematical models from data.
- 31 January 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (5) , eaav6971
Top Cited PapersOpen AccessA Bayesian machine scientist to aid in the solution of challenging scientific problems
A Bayesian machine scientist uncovers closed-form mathematical models from data.
- Open Access
- 23 March 2019
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (20) , 4089-4097
CliqueMS: a computational tool for annotating in-source metabolite ions from LC-MS untargeted metabolomics data based on a coelution similarity network
The analysis of biological samples in untargeted metabolomic studies using LC-MS yields tens of thousands of ion signals. Annotating these features is of the utmost importance for answering questions as fundamental as, e.g. how many metabolites are there in a given sample. Here, we introduce CliqueMS, a new algorithm for annotating in-source LC-MS1 data. CliqueMS is based on the similarity between coelution profiles and therefore, as opposed to most methods, allows for the annotation of a single spectrum. Furthermore, CliqueMS improves upon the state of the art in several dimensions: (i) it uses a more discriminatory feature similarity metric; (ii) it treats the similarities between features in a transparent way by means of a simple generative model; (iii) it uses a well-grounded maximum likelihood inference approach to group features; (iv) it uses empirical adduct frequencies to identify the parental mass and (v) it deals more flexibly with the identification of the parental mass by proposing and ranking alternative annotations. We validate our approach with simple mixtures of standards and with real complex biological samples. CliqueMS reduces the thousands of features typically obtained in complex samples to hundreds of metabolites, and it is able to correctly annotate more metabolites and adducts from a single spectrum than available tools. https://CRAN.R-project.org/package=cliqueMS and https://github.com/osenan/cliqueMS. Supplementary data are available at Bioinformatics online.
- 23 March 2019
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (20) , 4089-4097
Open AccessCliqueMS: a computational tool for annotating in-source metabolite ions from LC-MS untargeted metabolomics data based on a coelution similarity network
The analysis of biological samples in untargeted metabolomic studies using LC-MS yields tens of thousands of ion signals. Annotating these features is of the utmost importance for answering questions as fundamental as, e.g. how many metabolites are there in a given sample. Here, we introduce CliqueMS, a new algorithm for annotating in-source LC-MS1 data. CliqueMS is based on the similarity between coelution profiles and therefore, as opposed to most methods, allows for the annotation of a single spectrum. Furthermore, CliqueMS improves upon the state of the art in several dimensions: (i) it uses a more discriminatory feature similarity metric; (ii) it treats the similarities between features in a transparent way by means of a simple generative model; (iii) it uses a well-grounded maximum likelihood inference approach to group features; (iv) it uses empirical adduct frequencies to identify the parental mass and (v) it deals more flexibly with the identification of the parental mass by proposing and ranking alternative annotations. We validate our approach with simple mixtures of standards and with real complex biological samples. CliqueMS reduces the thousands of features typically obtained in complex samples to hundreds of metabolites, and it is able to correctly annotate more metabolites and adducts from a single spectrum than available tools. https://CRAN.R-project.org/package=cliqueMS and https://github.com/osenan/cliqueMS. Supplementary data are available at Bioinformatics online.
- 3 March 2017
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 89 (6) , 3474-3482
iMet: A Network-Based Computational Tool To Assist in the Annotation of Metabolites from Tandem Mass Spectra
Structural annotation of metabolites relies mainly on tandem mass spectrometry (MS/MS) analysis. However, approximately 90% of the known metabolites reported in metabolomic databases do not have annotated spectral data from standards. This situation has fostered the development of computational tools that predict fragmentation patterns in silico and compare these to experimental MS/MS spectra. However, because such methods require the molecular structure of the detected compound to be available for the algorithm, the identification of novel metabolites in organisms relevant for biotechnological and medical applications remains a challenge. Here, we present iMet, a computational tool that facilitates structural annotation of metabolites not described in databases. iMet uses MS/MS spectra and the exact mass of an unknown metabolite to identify metabolites in a reference database that are structurally similar to the unknown metabolite. The algorithm also suggests the chemical transformation that converts the known metabolites into the unknown one. As a proxy for the structural annotation of novel metabolites, we tested 148 metabolites following a leave-one-out cross-validation procedure or by using MS/MS spectra experimentally obtained in our laboratory. We show that for 89% of the 148 metabolites at least one of the top four matches identified by iMet enables the proper annotation of the unknown metabolites. To further validate iMet, we tested 31 metabolites proposed in the 2012–16 CASMI challenges. iMet is freely available at http://imet.seeslab.net.
- 3 March 2017
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 89 (6) , 3474-3482
iMet: A Network-Based Computational Tool To Assist in the Annotation of Metabolites from Tandem Mass Spectra
Structural annotation of metabolites relies mainly on tandem mass spectrometry (MS/MS) analysis. However, approximately 90% of the known metabolites reported in metabolomic databases do not have annotated spectral data from standards. This situation has fostered the development of computational tools that predict fragmentation patterns in silico and compare these to experimental MS/MS spectra. However, because such methods require the molecular structure of the detected compound to be available for the algorithm, the identification of novel metabolites in organisms relevant for biotechnological and medical applications remains a challenge. Here, we present iMet, a computational tool that facilitates structural annotation of metabolites not described in databases. iMet uses MS/MS spectra and the exact mass of an unknown metabolite to identify metabolites in a reference database that are structurally similar to the unknown metabolite. The algorithm also suggests the chemical transformation that converts the known metabolites into the unknown one. As a proxy for the structural annotation of novel metabolites, we tested 148 metabolites following a leave-one-out cross-validation procedure or by using MS/MS spectra experimentally obtained in our laboratory. We show that for 89% of the 148 metabolites at least one of the top four matches identified by iMet enables the proper annotation of the unknown metabolites. To further validate iMet, we tested 31 metabolites proposed in the 2012–16 CASMI challenges. iMet is freely available at http://imet.seeslab.net.
- Open Access
- 22 September 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 13606
A comprehensive study on different modelling approaches to predict platelet deposition rates in a perfusion chamber
Thrombus formation is a multiscale phenomenon triggered by platelet deposition over a protrombotic surface (eg. a ruptured atherosclerotic plaque). Despite the medical urgency for computational tools that aid in the early diagnosis of thrombotic events, the integration of computational models of thrombus formation at different scales requires a comprehensive understanding of the role and limitation of each modelling approach. We propose three different modelling approaches to predict platelet deposition. Specifically, we consider measurements of platelet deposition under blood flow conditions in a perfusion chamber for different time periods (3, 5, 10, 20 and 30 minutes) at shear rates of 212 s−1, 1390 s−1 and 1690 s−1. Our modelling approaches are: i) a model based on the mass-transfer boundary layer theory; ii) a machine-learning approach; and iii) a phenomenological model. The results indicate that the three approaches on average have median errors of 21%, 20.7% and 14.2%, respectively. Our study demonstrates the feasibility of using an empirical data set as a proxy for a real-patient scenario in which practitioners have accumulated data on a given number of patients and want to obtain a diagnosis for a new patient about whom they only have the current observation of a certain number of variables.
- 22 September 2015
- Published by Springer Nature in Scientific Reports
- Vol. 5 (1) , 13606
Open AccessA comprehensive study on different modelling approaches to predict platelet deposition rates in a perfusion chamber
Thrombus formation is a multiscale phenomenon triggered by platelet deposition over a protrombotic surface (eg. a ruptured atherosclerotic plaque). Despite the medical urgency for computational tools that aid in the early diagnosis of thrombotic events, the integration of computational models of thrombus formation at different scales requires a comprehensive understanding of the role and limitation of each modelling approach. We propose three different modelling approaches to predict platelet deposition. Specifically, we consider measurements of platelet deposition under blood flow conditions in a perfusion chamber for different time periods (3, 5, 10, 20 and 30 minutes) at shear rates of 212 s−1, 1390 s−1 and 1690 s−1. Our modelling approaches are: i) a model based on the mass-transfer boundary layer theory; ii) a machine-learning approach; and iii) a phenomenological model. The results indicate that the three approaches on average have median errors of 21%, 20.7% and 14.2%, respectively. Our study demonstrates the feasibility of using an empirical data set as a proxy for a real-patient scenario in which practitioners have accumulated data on a given number of patients and want to obtain a diagnosis for a new patient about whom they only have the current observation of a certain number of variables.
- 30 September 2010
- Published by Springer Nature in Theoretical Chemistry Accounts
- Vol. 128 (4-6) , 579-592
The reaction between HO and (H2O) n (n = 1, 3) clusters: reaction mechanisms and tunneling effects
- 30 September 2010
- Published by Springer Nature in Theoretical Chemistry Accounts
- Vol. 128 (4-6) , 579-592
The reaction between HO and (H2O) n (n = 1, 3) clusters: reaction mechanisms and tunneling effects
- 16 July 2010
- Published by Wiley in Journal of Computational Chemistry
- Vol. 31 (13) , 2510-2525
Implementation of an algorithm based on the Runge‐Kutta‐Fehlberg technique and the potential energy as a reaction coordinate to locate intrinsic reaction paths
The intrinsic reaction coordinate (IRC) curve is used widely as a representation of the Reaction Path and can be parameterized taking the potential energy as a reaction coordinate (Aguilar‐Mogas et al., J Chem Phys 2008, 128, 104102). Taking this parameterization and its variational nature, an algorithm is proposed that permits to locate this type of curve joining two points from an arbitrary curve that joints the same initial and final points. The initial and final points are minima of the potential energy surface associated with the geometry of reactants and products of the reaction whose mechanism is under study. The arbitrary curves are moved toward the IRC curve by a Runge‐Kutta‐Fehlberg technique. This technique integrates a set of differential equations resulting from the minimization until value zero of the line integral over the Weierstrass E‐function. The Weierstrass E‐function is related with the second variation in the theory of calculus of variations. The algorithm has been proved in real chemical systems. © 2010 Wiley Periodicals, Inc. J Comput Chem, 2010
- 16 July 2010
- Published by Wiley in Journal of Computational Chemistry
- Vol. 31 (13) , 2510-2525
Implementation of an algorithm based on the Runge‐Kutta‐Fehlberg technique and the potential energy as a reaction coordinate to locate intrinsic reaction paths
The intrinsic reaction coordinate (IRC) curve is used widely as a representation of the Reaction Path and can be parameterized taking the potential energy as a reaction coordinate (Aguilar‐Mogas et al., J Chem Phys 2008, 128, 104102). Taking this parameterization and its variational nature, an algorithm is proposed that permits to locate this type of curve joining two points from an arbitrary curve that joints the same initial and final points. The initial and final points are minima of the potential energy surface associated with the geometry of reactants and products of the reaction whose mechanism is under study. The arbitrary curves are moved toward the IRC curve by a Runge‐Kutta‐Fehlberg technique. This technique integrates a set of differential equations resulting from the minimization until value zero of the line integral over the Weierstrass E‐function. The Weierstrass E‐function is related with the second variation in the theory of calculus of variations. The algorithm has been proved in real chemical systems. © 2010 Wiley Periodicals, Inc. J Comput Chem, 2010